Press Releases

News

Roswell Park Hosts Networking Day for Neuroendocrine Cancer Patients

Patients and survivors treated for rare neuroendocrine cancers, along with their families, are invited to an informational networking event hosted by Roswell Park Cancer Institute on Saturday, August 29 from 9:00 a.m. to 2:15 p.m. at the Buffalo Niagara Marriott, 1340 Millersport Highway, Amherst, N.Y.
News

Community Outreach and Education Program Aims to Reduce Cancer Health Disparities

Roswell Park Cancer Institute (RPCI) researchers, together with input from African-American community leaders in Buffalo, have created an outreach effort that provides racial/ethnic minority and medically underserved communities with educational programs regarding the public’s participation in biomedical research.
News

Pilot Clinical Trial at Roswell Park Will Assess AGS-003 Immunotherapy in Kidney Cancer

Argos Therapeutics Inc., today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy, or treatment to shrink a tumor before surgery, in patients with localized renal-cell carcinoma. The study is being conducted at Roswell Park Cancer Institute and is designed to enroll a maximum of 10 patients who will be treated with AGS-003 before nephrectomy in order to assess immune-system response and tumor effects.
News

Dr. Oscar DeLeon Elected President of ASRA

New officers for the American Society of Regional Anesthesia and Pain Medicine began their terms at the 40th Annual Regional Anesthesiology and Pain Medicine Meeting, and the President of the prestigious organization is Roswell Park’s very own Oscar DeLeon, MD.